Experimental evidence suggested that resveratrol-treated ATC cells showed remarkable growth arrest and extensive apoptosis [27,29,51], and that it was able to reduce IL-1β expression in either in vivo or ex vivo human noncancerous models [52,53] or melanoma cells [54]. Here, IL1B is linked to melanoma.